Health Condition 1: B078- Other viral warts
Conditions
Interventions
Intervention1: 20% Podophyllin: Patients in group A with anogenital wart will be treated with 20% podophyllin application weekly once for 6 weeks and followed up 2 weeks interval for another 6 weeks f
Sponsors
Dr S Ramya
Eligibility
Inclusion criteria
Inclusion criteria: Patients with anogenital warts willing to give written informed consent will be divided into group A and group B.25 Patients in group A will receive 20% podophyllin.25 Patients in group B will receive 100% TCA. Maximum 6 sittings will be given at weekly interval. Patients will receive no other therapies during the study. Patients will be advised partner screening and usage of barrier contraception during the study.
Exclusion criteria
Exclusion criteria: Before starting the study Pregnant and lactating women. During the study If patient develops severe side effects like ulceration / intolerant to pain during the treatment. If patient wants alternate treatment during the study. If patient wants to discontinue the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical improvement or resolution of anogenital wartsTimepoint: 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Disappearance or Recurrence of of anogenital wartsTimepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactDr S Ramya
Chengalpattu Medical College and Hospital
Outcome results
None listed